Top compounds associated with response to LCNL1


Feature Type Standardized
Nominal ANOVA
mRNA 5-FU CTRPv2 pan-cancer AAC -0.078 0.02
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.02
mRNA Pyrimethamine GDSC1000 pan-cancer AAC -0.12 0.02
mRNA AZD6244 CCLE pan-cancer AAC -0.099 0.02
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.02
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.068 0.02
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.02
mRNA Midostaurin GDSC1000 pan-cancer AAC 0.077 0.02
mRNA dacarbazine CTRPv2 pan-cancer AAC -0.07 0.02
mRNA GW843682X GDSC1000 pan-cancer AAC -0.11 0.03
Download CSV